Bravelle Lawsuits Over Fertility Drug Recall
Last Updated on April 4, 2020
Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.
At A Glance
- This Alert Affects:
- Women who used Bravelle, a type of fertility drug, between March 2014 and October 2015.
- What's Going On?
- Lawsuits have been filed against Ferring Pharmaceuticals, the maker of Bravelle, after a recall was issued over the drug's lack of potency.
If you used Bravelle between March 2014 and October 2015, you may be able to file a lawsuit against the maker of the fertility drug for the money you spent on in-vitro fertilization (IVF) and intrauterine insemination (IUI) treatments.
Attorneys across the country have been speaking with women who used Bravelle about their options for pursuing legal action following a recall over the drug’s lack of efficacy.
Following an October 2015 recall of Bravelle, Ferring Pharmaceuticals offered women reimbursement for money spent on the fertility drug. The company, however, is reportedly failing to offer compensation to women for the costs of their IVF treatments.
It's believed that women may be able to sue Ferring for the cost of their failed IVF treatments – costs that well exceed the minimal reimbursement the company is reportedly offering patients. One lawsuit has already been filed alleging that the drug maker owes the plaintiff $20,000 to $25,000 in out-of-pocket costs related to the IVF process.
Bravelle Recall: What Happened?
In October 2015, Ferring Pharmaceuticals reportedly sent out letters to patients informing them that the company was voluntarily recalling Bravelle after tests revealed that certain batches of the drug weren’t as effective as they should have been. Although the recall only affected certain lots – mainly those purchased between March 2014 and October 2015 – the company decided to remove all remaining lots from the U.S. market.
The lawsuit against Ferring Pharmaceuticals alleges that the lots that suffered from decreased potency not only had a lower therapeutic effect, but that also exposed women to unnecessary health risks. Fertility drugs – even those taken at low doses – have been linked to certain serious side effects including blood clots, ovarian torsion, birth defects and ovarian hyper-stimulation syndrome.
Despite the recall, Bravelle’s website continues to market and advertise the drug to consumers without any warning about the potency problems and offers patients no way to determine whether they purchased and used drugs from the lots subject to the recall.
If You Used Bravelle, You May Be Able To Take Action
A number of women have claimed that Bravelle did not work and have argued that they are owed money beyond the reimbursement Ferring is offering patients. If you used Bravelle between March 2014 and October 2015, it’s possible that you may be able to file a lawsuit against the company to recover compensation for costs related to the IVF treatments – not just the failed hormone injections.
Before commenting, please review our comment policy.